share_log

Outset Medical (NASDAQ:OM) & Vivani Medical (NASDAQ:VANI) Head-To-Head Comparison

Outset Medical (NASDAQ:OM) & Vivani Medical (NASDAQ:VANI) Head-To-Head Comparison

一開始醫療(納斯達克:OM)和維萬尼醫療(納斯達克:凡尼)頭對頭比較
Defense World ·  2023/01/22 01:51

Outset Medical (NASDAQ:OM – Get Rating) and Vivani Medical (NASDAQ:VANI – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, analyst recommendations and dividends.

一開始醫療 (NASDAQ: OM — 獲得評級) 和維萬尼醫療 (NASDAQ: VANI — 獲得評級) 都是小型股醫療公司, 但這是優越的投資?我們將根據兩家公司的估值,收益,盈利能力,風險,機構所有權,分析師建議和股息來對比兩家公司。

Profitability

盈利

This table compares Outset Medical and Vivani Medical's net margins, return on equity and return on assets.

此表格比較了首達醫療和薇萬尼醫療的淨利潤率、股本回報率和資產回報率。

Get
取得
Outset Medical
開始醫療
alerts:
警報:
Net Margins Return on Equity Return on Assets
Outset Medical -145.93% -49.75% -39.16%
Vivani Medical N/A -8.27% -7.86%
淨利潤 權益回報率 資產回報率
開始醫療 -145.93% -49.75% -39.16%
維瓦尼醫療 N/A -8.27% -7.86%

Analyst Ratings

分析師評級

This is a summary of current ratings for Outset Medical and Vivani Medical, as provided by MarketBeat.com.

這是當前評級的開始醫療和維萬尼醫療的摘要, 由 MarketBeat.com 提供.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Outset Medical 0 1 4 0 2.80
Vivani Medical 0 0 1 0 3.00
銷售評級 保留評分 購買評級 強大的買入評級 評級分數
開始醫療 0 1 4 0 2.80
維瓦尼醫療 0 0 1 0 3.00
Outset Medical currently has a consensus price target of $24.50, indicating a potential downside of 9.46%. Vivani Medical has a consensus price target of $7.00, indicating a potential upside of 478.51%. Given Vivani Medical's stronger consensus rating and higher probable upside, analysts plainly believe Vivani Medical is more favorable than Outset Medical.
一開始醫療目前的共識價格目標為 24.50 美元,表明潛在的下行為 9.46%。維萬尼醫療的共識價格目標為 7.00 美元,表明潛在的上行空間為 478.51%。鑑於 Vivani Medical 更強大的共識評級和更高的可能上行空間,分析師清楚地認為 Vivani Medical 比開始醫療更有利。

Institutional & Insider Ownership

機構和內幕所有權

98.8% of Outset Medical shares are owned by institutional investors. 4.0% of Outset Medical shares are owned by insiders. Comparatively, 47.2% of Vivani Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

98.8% 的首發醫療股份由機構投資者擁有。首發醫療股份的 4.0% 由內部人士擁有。相比之下,Vivani 醫療股份的 47.2% 由內部人士擁有。強大的機構所有權表明,捐贈基金,大型資金經理和對沖基金認為股票將在長期內優於市場。

Valuation and Earnings

估值及收益

This table compares Outset Medical and Vivani Medical's revenue, earnings per share (EPS) and valuation.

此表格比較首創醫療和薇凡尼醫療的收入、每股盈利和估值。

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Outset Medical $102.60 million 12.74 -$131.93 million ($3.42) -7.91
Vivani Medical N/A N/A -$8.92 million N/A N/A
總收入 價格/銷售比率 淨收入 每股盈利 市盈比率
開始醫療 一億二千六百萬 12.74 -1.93 億美元 (三百四十二元) -7.91
維瓦尼醫療 N/A N/A -892 萬美元 N/A N/A

Vivani Medical has lower revenue, but higher earnings than Outset Medical.

維萬尼醫療的收入較低,但收益高於首發醫療。

Risk & Volatility

風險及波動性

Outset Medical has a beta of 1.49, suggesting that its stock price is 49% more volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 2.54, suggesting that its stock price is 154% more volatile than the S&P 500.

一開始醫療的測試版為 1.49,表明其股票價格比標普 500 的波動性高 49%。相比之下,維萬尼醫療的測試版為 2.54,這表明其股票價格比標普 500 的波動性高 154%。

Summary

摘要

Vivani Medical beats Outset Medical on 8 of the 11 factors compared between the two stocks.

維瓦尼醫療擊敗開始醫療 8 的 11 因素兩個股票之間的比較.

About Outset Medical

關於開智醫療

(Get Rating)

(取得評分)

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

醫療技術公司 Outset 醫療股份有限公司開發了用於透析的血液透析系統。它提供了 Tablo 血液透析系統,該系統包括一個緊湊型控制台,具有集成水淨化,按需透析生產以及用於急性和家庭環境的透析護理的軟件和連接功能。該公司以前被稱為家庭透析加, 有限公司和更名為開始醫療, 公司在一月 2015.一開始醫療有限公司成立於 2003 年,總部位於加利福尼亞州聖何塞。

About Vivani Medical

關於薇萬尼醫療

(Get Rating)

(取得評分)

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

Vivani Medical, Inc. 是一家臨床階段公司,開發各種植入物,用於治療尚未滿足的高度醫療需求的慢性疾病。它致力於開發微型藥物植入物的產品組合,以提供最小波動的藥物特徵;以及可植入的視覺假肢裝置,為盲人提供有用的人工視覺。該公司總部位於加利福尼亞州埃默里維爾。

Receive News & Ratings for Outset Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Outset Medical and related companies with MarketBeat.com's FREE daily email newsletter.

接收有關「開始醫療日報」的新聞和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收有關首發醫療和相關公司的最新新聞和分析師評級的簡要每日摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論